SE

Serinus Biosciences

YC S22

New York City, US · Founded 2022 · 6 employees · 2 known investors

serinus.bio ↗

Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.

Founders & leadership· Y Combinator alumni (S22)

Adam Yaariin𝕏Founder/CEO

Maxwell Shermanin𝕏Founder/CTO

Investors · 2

IL

Illumina VenturesFoster City

Y

Y CombinatorMountain View · $500K – $500K